KWILP
BHVN

Kiwi Wealth Investments Limited Partnership’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Kiwi Wealth Investments Limited Partnership’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-11,913
Closed -$1.41M – 248
2022
Q1 		$1.41M Buy
+11,913
New +$1.49M 0.08% 181

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Kiwi Wealth Investments Limited Partnership's BHVN Position: Q2 2022 in Review

Kiwi Wealth Investments Limited Partnership sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q2 2022, closing a stake of 11,913 shares — an estimated $1.41M sold.

Kiwi Wealth Investments Limited Partnership first reported a position in BHVN in Q1 2022 and held it in 1 quarter. The position peaked at $1.41M in Q1 2022. 329 funds tracked by Wall St. Rank hold BHVN as of Q2 2022.

  • Kiwi Wealth Investments Limited Partnership reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q2 2022 after selling out during the quarter.
  • Kiwi Wealth Investments Limited Partnership sold 11,913 Biohaven Pharmaceutical Holding Company Ltd. shares in Q2 2022, an estimated $1.41M.
  • Kiwi Wealth Investments Limited Partnership first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2022 and held it in 1 quarter.
  • Kiwi Wealth Investments Limited Partnership's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.41M in Q1 2022.
  • 329 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q2 2022.

Based on Kiwi Wealth Investments Limited Partnership's 13F filing for Q2 2022, filed 12 Aug 2022.